Prof. Dr. Gisbert Schneider
Prof. Dr. Gisbert Schneider
Full Professor at the Department of Biosystems Science and Engineering
Additional information
Research area
Gisbert Schneider’s research activities focus on the development and application of adaptive intelligent systems for molecular design and drug discovery. Homepage: www.modlab.ethz.ch
Gisbert Schneider received a doctorate in biochemistry from the Freie Universität Berlin, Germany, in 1994, where he also studied medicine and computer science.
He then worked as a postdoctoral researcher at the Benjamin Franklin University Clinic, Berlin, the Massachusetts Institute of Technology in Cambridge, MA, the University of Stockholm, Sweden, and the Max-Planck-Institute of Biophysics in Frankfurt, Germany.
From 1997 to 2001 he worked as a scientific specialist in the Pharmaceuticals Division at Hoffmann – La Roche Ltd, Basel, Switzerland.
In 2000, he received the venia legendi for biochemistry and bioinformatics from the University of Freiburg, Germany.
From 2002 to 2009, Gisbert Schneider was a full professor at Goethe-University in Frankfurt, Germany (Beilstein Endowed Chair for Chem- and Bioinformatics).
Since 2010, he has been full professor of Computer-Assisted Drug Design at the Institute of Pharmaceutical Sciences in the Department of Chemistry and Applied Biosciences, ETH Zurich.
From 2018 to 2020 he served as Associate Vice President for ETH Global and as founding Director of the ETH RETHINK think-and-do tank.
In 2021, he became Director of the Singapore-ETH Center in Singapore, where he currently serves on the Board of Directors.
Since 2024, he has served as a member of the Council of the Swiss Innovation Agency, Innosuisse.
He is a co-founder of Endogena Therapeutics Inc., Xanydys LLC, and AlloCyte Pharmaceuticals AG, and inSili.com LLC, an ETH spin-off company.
Gisbert Schneider has received numerous awards internationally, including the Ernst Schering Prize, Gmelin-Beilstein Award, Herman Skolnik Award, Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery, and the Falling Walls Science Breakthrough of the Year Award. He is an Elected Fellow of the University of Tokyo and Honorary Adjunct Professor at Goethe-University Frankfurt.
Membership
| Since | Membership |
|---|---|
| American Chemical Society (ACS) | |
| Gesellschaft Deutscher Chemiker (GDCh) | |
| Schweizerische Chemische Gesellschaft (SCG) |
Honours
| Year | Distinction |
|---|---|
| 2024 | Highly Cited Researcher (Clarivate) |
| 2024 | Provost's Chair Visiting Professor, Yong Loo Lin School of Medicine, National University of Singapore (NUS) |
| 2023 | Dieter Binder Lectureship on Medicinal Chemistry (Austrian Chemical Society) |
| 2023 | Highly Cited Researcher (Clarivate) |
| 2022 | Ernst Schering Prize |
| 2022 | Gmelin-Beilstein Award |
| 2022 | Highly Cited Researcher (Clarivate) |
| 2021 | Falling Walls Science Breakthrough of the Year |
| 2021 | Highly Cited Researcher (Clarivate) |
| 2020 | Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery |
| 2018 | Falling Walls Circle, Berlin, Germany |
| 2018 | Herman Skolnik Award of the American Chemical Society, USA |
| 2015 | Fellow of The University of Tokyo (honorary title), The University of Tokyo, Japan |
| 2015 | Tour Lecturer of the Molecular Graphics and Modelling Society, UK |
| 2014 | Golden Owl (teaching award), ETH Zurich |
| 2014 | Highly Cited Researcher (Thomson Reuters) |
| 2010 | Appointed Adjunct Professor (honorary title), Goethe University, Frankfurt, Germany |
| 2008 | Visiting professor at the Université Louis Pasteur, Strasbourg, France |
| 2006 | Professor of the Year in the category of sciences and medicine (national award), Germany |
Additional information
Professor Schneider authored more than 400 scientific publications and holds numerous patents.
Course Catalogue
Spring Semester 2025
| Number | Unit |
|---|---|
| 535-0900-00L | Seminars on Drug Discovery and Development |
| 535-2000-00L | Seminar for Group Members |